Other
Interest Paid, Net
Vertex Pharmaceuticals Interest Paid, Net increased by 6.7% to $3.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.5%, from $2.70M to $3.20M. Over 4 years (FY 2021 to FY 2025), Interest Paid, Net shows a downward trend with a -31.5% CAGR.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2016
Last reportedQ1 2026May 5, 2026
Metric ID:
ms_interest_paid_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.60M | $12.60M | $13.60M | $13.70M | $13.40M | $14.00M | $11.20M | $10.78M | $10.78M | $10.78M | $10.78M | $10.00M | $9.70M | $8.10M | $2.70M | $2.70M | $3.50M | $3.20M | $3.00M | $3.20M |
| QoQ Change | — | -19.2% | +7.9% | +0.7% | -2.2% | +4.5% | -20.0% | -3.8% | +0.0% | +0.0% | +0.0% | -7.2% | -3.0% | -16.5% | -66.7% | +0.0% | +29.6% | -8.6% | -6.3% | +6.7% |
| YoY Change | — | — | — | — | -14.1% | +11.1% | -17.6% | -21.4% | -19.6% | -23.0% | -3.8% | -7.2% | -10.0% | -24.8% | -74.9% | -73.0% | -63.9% | -60.5% | +11.1% | +18.5% |
Range$2.70M – $15.60M
CAGR-28.4%
Avg YoY Growth-23.3%
Median YoY Growth-18.6%
Interest Paid, Net at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's interest paid, net?
- Vertex Pharmaceuticals (VRTX) reported interest paid, net of $3.20M in Q1 2026.
- How has Vertex Pharmaceuticals's interest paid, net changed year-over-year?
- Vertex Pharmaceuticals's interest paid, net increased by 18.5% year-over-year, from $2.70M to $3.20M.
- What is the long-term trend for Vertex Pharmaceuticals's interest paid, net?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's interest paid, net has grown at a -31.5% compound annual growth rate (CAGR), from $56.30M to $12.40M.